Middleton, WI (June 2, 2016) – Gilson today announces the launch of EXTRACTMAN®, an innovative biomolecule extraction platform that enables researchers to better study complex protein interactions that are critical for drug target identification and a wide variety of topics in proteomic research. EXTRACTMAN® is ideal for protein interaction studies because it can isolate weak interactors and transiently bound complexes that traditional isolation techniques leave behind. These weak interactors represent potentially unseen targets that are integral to fully understanding protein functions, molecular mechanisms, post-translational modifications and cell signaling cascades.
Protein isolation using EXTRACTMAN® can be performed in significantly less time compared to more traditional tube-based magnetic bead procedures, with up to four samples isolated in parallel in as little as 30 seconds. The EXTRACTMAN® protocol is also ideal for capturing weakly bound protein-protein and cell-protein complexes because they are not exposed to the high shear forces generated by multiple pipet-based wash steps and require less time in pro-dissociating wash buffers.
Read the full press release here at Gilson.com: http://www.gilson.com/en/About/News/216/#.V11y9JErK02